(Q39096624)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24030360%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

title

Cannabinoid effects on β amyloid fibril and aggregate formation, neuronal and microglial-activated neurotoxicity in vitro (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24030360%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

0 references

1 reference

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24030360%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

author name string

Emelie Janefjord

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24030360%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Benjamin S Harvey

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24030360%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Scott D Smid

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24030360%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

publication date

13 September 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24030360%20AND%20SRC:MED&resulttype=core&format=json

Cellular and Molecular Neurobiology

21 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24030360%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24030360%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24030360%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

page(s)

31-42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24030360%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10571-013-9984-x

21 February 2020

exact match

0 references

cites work

The atypical cannabinoid O-1602: targets, actions, and the central nervous system

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9984-X

EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9984-X

The role of the endocannabinoid system in Alzheimer's disease: facts and hypotheses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9984-X

Peroxisome-proliferator-activated receptor gamma induces a clearance mechanism for the amyloid-beta peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9984-X

Differentiation increases the resistance of neuronal cells to amyloid toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9984-X

Replicating neuroblastoma cells in different cell cycle phases display different vulnerability to amyloid toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9984-X

Endocannabinoid 2-arachidonoylglycerol protects neurons against β-amyloid insults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9984-X

Monoacylglycerol lipase is a therapeutic target for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9984-X

Nonpsychoactive cannabidiol prevents prion accumulation and protects neurons against prion toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9984-X

Vitamin E (alpha-tocopherol) attenuates cyclo-oxygenase 2 transcription and synthesis in immortalized murine BV-2 microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9984-X

Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in beta-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-kappaB involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9984-X

Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9984-X

Cannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9984-X

The endocannabinoid system as a target for the treatment of neuronal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9984-X

Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9984-X

Cannabinoids inhibit migration of microglial-like cells to the HIV protein Tat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9984-X

Differential toxicity, conformation and morphology of typical initial aggregation states of Aβ1-42 and Aβpy3-42 beta-amyloids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9984-X

Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9984-X

Contrasting protective effects of cannabinoids against oxidative stress and amyloid-β evoked neurotoxicity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9984-X

Differential effects of albumin on microglia and macrophages; implications for neurodegeneration following blood-brain barrier damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9984-X

Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9984-X

The thioflavin T fluorescence assay for amyloid fibril detection can be biased by the presence of exogenous compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9984-X

Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9984-X

Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9984-X

The therapeutic potential of the endocannabinoid system for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9984-X

Mechanism of thioflavin T binding to amyloid fibrils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9984-X

2-Arachidonoylglycerol elicits neuroprotective effects on excitotoxically lesioned dentate gyrus granule cells via abnormal-cannabidiol-sensitive receptors on microglial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9984-X

Resveratrol selectively remodels soluble oligomers and fibrils of amyloid Abeta into off-pathway conformers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9984-X

Soluble Aβ seeds are potent inducers of cerebral β-amyloid deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9984-X

Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9984-X

N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9984-X

Anandamide and noladin ether prevent neurotoxicity of the human amyloid-beta peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9984-X

Microglial phagocytosis induced by fibrillar β-amyloid is attenuated by oligomeric β-amyloid: implications for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9984-X

CB1 cannabinoid receptors are involved in neuroprotection via NF-kappa B inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9984-X

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9984-X

A dysregulated endocannabinoid-eicosanoid network supports pathogenesis in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9984-X

Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9984-X

Cannabidiol targets mitochondria to regulate intracellular Ca2+ levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9984-X

The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9984-X

The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9984-X

Endocannabinoid signaling in microglial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9984-X

Cannabinoid activation of PPAR alpha; a novel neuroprotective mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9984-X

Role of toll-like receptor signalling in Abeta uptake and clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9984-X

The monoacylglycerol lipase inhibitor JZL184 attenuates LPS-induced increases in cytokine expression in the rat frontal cortex and plasma: differential mechanisms of action

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24030360

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Targeting the endocannabinoid system in Alzheimer's disease.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24030360

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The effects of pH and temperature on the in vitro bindings of delta-9-tetrahydrocannabinol and other cannabinoids to bovine serum albumin

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24030360

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S10571-013-9984-X

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24030360%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference